FAQ

Non-Resectable Hepatocellular Carcinoma

A hepatocellular carcinoma that is not amenable to surgical resection.
National Institutes of Health

Topic mentions per year

Topic mentions per year

1983-2017
02419832017

Related topics

Related topics

23 relations
Abdominal PainAberrant DNA MethylationAdenocarcinoma CellBile Ducts, Extrahepatic
(More)

Related mentions per year

Related mentions per year

1936-2019
19401960198020002020
Non-Resectable Hepatocellular Carcinoma
cancer cell
Fever
Hepatocyte
Abdominal Pain
Neoplastic Cell

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Adjuvant stereotactic body radiotherapy following transarterial chemoembolization in patients with non-resectable hepatocellular carcinoma tumours of ≥ 3 cm.
OBJECTIVES The optimal locoregional treatment for non-resectable hepatocellular carcinoma (HCC) of ≥ 3 cm in diameter is unclear… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • figure 3
Is this relevant?
2008
2008
Prognostic factors of survival in patients with non-resectable hepatocellular carcinoma: hepatitis C versus miscellaneous etiology.
OBJECTIVE To identify prognostic determinants of survival in patients with non-resectable hepatocellular carcinoma (HCC… (More)
Is this relevant?
2008
2008
Stereotactic body radiation therapy with or without transarterial chemoembolization for patients with primary hepatocellular carcinoma: preliminary analysis
The objectives of this retrospective study was to evaluate the efficacy of stereotactic body radiation therapy (SBRT) for small… (More)
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2007
2007
Transarterial chemoembolization using degradable starch microspheres and iodized oil in the treatment of advanced hepatocellular carcinoma: evaluation of tumor response, toxicity, and survival.
BACKGROUND In a multidisciplinary conference patients with advanced non-resectable hepatocellular carcinoma (HCC) were stratified… (More)
Is this relevant?
2004
2004
[Long-term results of interventional treatment of large unresectable hepatocellular carcinoma (HCC): significant survival benefit from combined transcatheter arterial chemoembolization (TACE) and…
PURPOSE A retrospective analysis of long-term efficacy of combined transcatheter arterial chemoembolization (TACE) and… (More)
Is this relevant?
2002
2002
Treatment of non-resectable hepatocellular carcinoma with autologous tumor-pulsed dendritic cells.
BACKGROUND The response of hepatocellular carcinoma (HCC) to therapy is often disappointing and new modalities of treatment are… (More)
Is this relevant?
2002
2002
Prognostic factors in patients with hepatocellular carcinoma treated by transcatheter arterial embolization.
BACKGROUND Transcatheter arterial embolization induces marked antitumor response in patients with hepatocellular carcinoma, but… (More)
  • table 1
  • figure 1
  • figure 2
  • table 2
Is this relevant?
1990
1990
[Lipiodol transcatheter arterial chemoembolization for non-resectable hepatocellular carcinoma--multicenter cooperative study].
A cooperative group study was carried out on the effect of Lipiodol transcatheter arterial chemo-embolization (L-TACE) for non… (More)
Is this relevant?
1989
1989
Arterial chemotherapy and transcatheter arterial embolization therapy for non-resectable hepatocellular carcinoma
An assessment was made on the therapeutic effects of arterial chemotherapy and transcatheter arterial embolization (TAE) therapy… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
1986
1986
[Intra-arterial administration of epirubicin in the treatment of non-resectable hepatocellular carcinoma. Epirubicin Study Group for Hepatocellular Carcinoma].
A group study was conducted to investigate the effect of intra-hepatic arterial administration of epirubicin in the treatment of… (More)
Is this relevant?